Fennec Pharmaceuticals (FENC) Profit After Tax Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | -141.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -141.16% |
| Sep 30, 2025 | 88.88% |
| Jun 30, 2025 | 43.24% |
| Mar 31, 2025 | -109.08% |
| Dec 31, 2024 | 25.99% |
| Sep 30, 2024 | -207.18% |
| Jun 30, 2024 | -2.00% |
| Mar 31, 2024 | 312.11% |
| Dec 31, 2023 | 60.12% |
| Sep 30, 2023 | 76.64% |
| Jun 30, 2023 | -7.65% |
| Mar 31, 2023 | -68.34% |
| Dec 31, 2022 | -58.04% |
| Sep 30, 2022 | -89.66% |
| Jun 30, 2022 | -29.10% |
| Mar 31, 2022 | 26.80% |
| Dec 31, 2021 | -27.69% |
| Sep 30, 2021 | 27.79% |
| Jun 30, 2021 | 18.87% |
| Mar 31, 2021 | -29.24% |
| Dec 31, 2020 | 7.00% |
| Sep 30, 2020 | -225.54% |
| Jun 30, 2020 | -2.66% |
| Mar 31, 2020 | -44.71% |
| Dec 31, 2019 | -20.11% |
| Sep 30, 2019 | 34.78% |
| Jun 30, 2019 | -81.79% |
| Mar 31, 2019 | -67.47% |
| Dec 31, 2018 | -30.31% |
| Sep 30, 2018 | -16.88% |
| Jun 30, 2018 | -61.89% |
| Mar 31, 2018 | -94.54% |
| Dec 31, 2017 | -100.35% |
| Sep 30, 2017 | -368.53% |
| Jun 30, 2017 | -120.72% |
| Mar 31, 2017 | -91.90% |
| Dec 31, 2016 | -111.67% |
| Sep 30, 2016 | -308.13% |
| Jun 30, 2016 | -318.50% |
| Mar 31, 2016 | -337.29% |
| Dec 31, 2015 | -138.90% |
| Sep 30, 2015 | -132.37% |
| Jun 30, 2015 | 76.93% |
| Mar 31, 2015 | 105.54% |
| Dec 31, 2014 | 24.93% |
| Sep 30, 2014 | 121.52% |
| Jun 30, 2014 | -111.35% |
| Mar 31, 2014 | 22.25% |
| Dec 31, 2013 | 117.06% |
| Sep 30, 2013 | -131.15% |
| Jun 30, 2013 | 1,197.51% |
| Mar 31, 2013 | -251.31% |
| Dec 31, 2012 | -285.55% |
| Sep 30, 2012 | 75.70% |
| Jun 30, 2012 | -72.99% |
| Mar 31, 2012 | -41.85% |
| Dec 31, 2011 | 153.30% |
| Sep 30, 2011 | -285.60% |
| Jun 30, 2011 | 86.45% |